# Alan Chan

> Alan Chan is a seed investor at Vectr (Hong Kong) backing AgTech and Cosmetics. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Vectr](https://shizune.co/investors/profile/vectr)
- Location: Hong Kong, Hong Kong
- Total investments: 5
- Last investment: Dec 2021
- Lead investor: 80%
- Last updated: Aug 2026
- LinkedIn: https://hk.linkedin.com/in/alan-chan-34b34b7
- X (Twitter): https://twitter.com/achanman

Alan Chan is a seed investor at Vectr in Hong Kong focused on AgTech and Cosmetics. Alan Chan - Co-Founder & Managing Partner @ Vectr

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| AgTech | 1 | 20% |
| Cosmetics | 1 | 20% |
| GreenTech | 1 | 20% |
| Nutrition | 1 | 20% |
| Agriculture | 1 | 20% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 60% |
| Series A | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| Australia | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Provectus Algae | Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $11.4M | Seed | Dec 14, 2021 |  |
| Plantible Foods | Plantible Foods is a B2B food technology company producing sustainable plant-based protein to optimize the food industry. The company develops a proprietary and vertically integrated agricultural manufacturing platform to allow food companies to innovate while optimizing costs and delivering products with improved taste, texture, health, andenvironmental footprint. | $21.5M | Series A | Sep 02, 2021 |  |
| Provectus Algae | Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $3.3M | Seed | Oct 21, 2020 |  |
| Plantible Foods | Plantible Foods is a B2B food technology company producing sustainable plant-based protein to optimize the food industry. The company develops a proprietary and vertically integrated agricultural manufacturing platform to allow food companies to innovate while optimizing costs and delivering products with improved taste, texture, health, andenvironmental footprint. | $4.6M | Seed | Apr 30, 2020 |  |
| NextVR | NextVR enables the transmission of live, long-form virtual reality content in broadcast quality – leading the way for live and on-demand VR to become a mainstream experience for sporting events, concerts, cinematic productions and more. Launched in 2009, NextVR has more than 26 patents granted or pending for the capture, compression, transmission,and display of virtual reality content. NextVR's platform allows the fully immersive content to be streamed with pristine quality using current home and mobile Internet connections. NextVR was founded by veterans in stereoscopic imaging technology, software development and an award-winning filmmaker | $5M | Seed | Sep 09, 2014 |  |

5 of 5 investments shown.

## Co-investors
- [Eighteen94 Capital](https://shizune.co/investors/profile/eighteen94-capital) — VC Fund, 2 deals together
- [FTW Ventures](https://shizune.co/investors/profile/ftw-ventures) — VC Fund, 2 deals together
- [Lerer Hippeau](https://shizune.co/investors/profile/lerer-ventures) — VC Fund, 2 deals together
- [Acequia Capital (AceCap)](https://shizune.co/investors/profile/acequia-capital) — VC Fund, 1 deal together
- [Astanor Ventures](https://shizune.co/investors/profile/astanor-ventures) — VC Fund, 1 deal together
- [CJ CheilJedang Corp.](https://shizune.co/investors/profile/cj-cheiljedang-corp) — VC Fund, 1 deal together

## About Vectr

VC Fund · Sheung Wan, Hong Kong

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

5 contacts available at Vectr.

| Name | Title | Profile |
| --- | --- | --- |
| Adrian Chan | Co-Founder and Partner | https://shizune.co/investors/profile/adrian-chan-2 |
| Alan Chan | Co-Founder & Managing Partner | https://shizune.co/investors/profile/alan-chan-3 |
| Andy Chen | Venture Partner | https://shizune.co/investors/profile/andy-chen-3 |
| Arthur Law | General Partner | https://shizune.co/investors/profile/arthur-law-3 |
| Esther Loewy | Venture Partner | https://shizune.co/investors/profile/esther-loewy |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Alan Chan invest in?

Alan Chan invests primarily in AgTech, Cosmetics and GreenTech startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alan Chan last invest?

The most recent investment recorded for Alan Chan closed in Dec 2021. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co